Popular on TelAve
- Amicly Launches as a Safety-First Social App Designed to Help People Build Real, Meaningful Friendships
- Purple Heart Recipient Honored by Hall of Fame Son In Viral Tribute Sparking National Conversation on Service Fatherhood, Healing and Legacy
- Triple-Digit Growth, Strategic N A S D A Q Uplist, Plus A Scalable Healthcare Rollout Model: Stock Symbol: CDIX
- Special Alert: Undervalued Opportunity: IQSTEL (N A S D A Q: IQST) Positioned for Explosive Multi-Year Growth
- Cancun All Inclusive is ready for Spring Break 2026 with new Resorts, Exclusive Deals, activities and more!
- Conexwest: Shipping Containers Are Powering the Next Generation of Bitcoin Mining Infrastructure
- Atlanta Tech Founder Seeks Clarity on Intellectual Property and Innovation Policy
- Lineus Medical's SafeBreak® Vascular Added to Alliant GPO Contract
- New Book Warring From the Standpoint of the Throne Room Calls Believers to Pray From Victory
- At 25, She Became One of the Youngest AAPI Female Founders to Win One of the World's Most Prestigious Design Awards for a Lamp That Makes You Smile
Similar on TelAve
- The Inner Power of Emotional Self-Leadership
- Dr. Nadene Rose Shares the Secret to True Success: Faith, Obedience, and Divine Purpose
- Award-Winning REALTOR® Paige Coker Joins Corcoran DeRonja Real Estate
- TicTac Group acquires French EdTech company Distrisoft
- Newborn Care Network Introduces Clinical Standard to Bridge the Six-Week Postpartum Gap
- The AAA Metamorphosis: How Global Gaming Is Redefining Production Standards
- Monexplora Explains the Options Mechanics Behind March's Tech Selloff and VIX Surge
- EFA Announces 2026 Editorial Rate Chart
- AI Disruption Meets Marine Scale: Off The Hook YS, Inc. (N Y S E American: OTH) Targets Breakout Growth with NextBoat Launch and Aggressive Expansion
- Targeting the Billion-Dollar U.S. Countermeasure Market With AI-Driven Biodefense Platform: Lunai Bioworks (N A S D A Q: LNAI)
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TelAve News/10821110
CAMBRIDGE, Mass. ~ On February 29, 2024, Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a leading company in precision genetic medicine for rare diseases, announced the granting of equity awards to five individuals who were recently hired by the company. These awards were previously approved by the Compensation Committee of Sarepta's Board of Directors under the 2014 Employment Commencement Incentive Plan and were given as a material inducement to employment.
According to Nasdaq Listing Rule 5635(c)(4), the equity awards included options to purchase a total of 6,300 shares of Sarepta's common stock and 6,300 restricted stock units (RSUs). The options have an exercise price of $127.90 per share, which is equivalent to the closing price of Sarepta's common stock on the day they were granted.
More on TelAve News
The options will vest over a period of four years, with one-fourth of the shares underlying each employee's option vesting on the one-year anniversary of the grant date. After that, 1/48th of the shares will vest monthly until all shares are fully vested on the fourth anniversary of the grant date. However, this is subject to each employee's continued employment with Sarepta on each vesting date.
Similarly, one-fourth of the RSUs will vest yearly on each anniversary of the grant date until they are fully vested on the fourth anniversary. Again, this is subject to each employee's continued employment with Sarepta.
This announcement highlights Sarepta's commitment to attracting and retaining top talent in their efforts towards precision genetic medicine for rare diseases. The company believes that these equity awards will serve as a strong incentive for employees to contribute towards their mission and drive success in their field.
According to Nasdaq Listing Rule 5635(c)(4), the equity awards included options to purchase a total of 6,300 shares of Sarepta's common stock and 6,300 restricted stock units (RSUs). The options have an exercise price of $127.90 per share, which is equivalent to the closing price of Sarepta's common stock on the day they were granted.
More on TelAve News
- Dr. Nadene Rose Shares the Secret to True Success: Faith, Obedience, and Divine Purpose
- Understanding Unexpected Death: Why Independent Autopsies Matter in Cases Without Clear Cause
- Epic Pictures Group Sets North American Release Date for the Thriller NO ORDINARY HEIST
- Award-Winning REALTOR® Paige Coker Joins Corcoran DeRonja Real Estate
- Over 98% of crypto owners globally don't declare taxes, new report find
The options will vest over a period of four years, with one-fourth of the shares underlying each employee's option vesting on the one-year anniversary of the grant date. After that, 1/48th of the shares will vest monthly until all shares are fully vested on the fourth anniversary of the grant date. However, this is subject to each employee's continued employment with Sarepta on each vesting date.
Similarly, one-fourth of the RSUs will vest yearly on each anniversary of the grant date until they are fully vested on the fourth anniversary. Again, this is subject to each employee's continued employment with Sarepta.
This announcement highlights Sarepta's commitment to attracting and retaining top talent in their efforts towards precision genetic medicine for rare diseases. The company believes that these equity awards will serve as a strong incentive for employees to contribute towards their mission and drive success in their field.
0 Comments
Latest on TelAve News
- Monexplora Explains the Options Mechanics Behind March's Tech Selloff and VIX Surge
- Larry R. Wasion Highlights Jump Gate I: Time Chair. The Opening Novel in His Expansive Science Fiction Series
- New Book Reveals The Science Of Predictions
- Compliance Alert: Maryland, Texas Regulate Use of Artificial Intelligence in Utilization Reviews
- Colony Ridge Communities Celebrates Successful Soccer Season Kickoff with Families and Youth
- Blackfoot Communications Expands Into New Rural Digital Opportunity Fund With netElastic vBNG and CGNAT Networking Software
- EFA Announces 2026 Editorial Rate Chart
- NYC Composer/Educator Launches Debut Children's Book to Fantastic Reviews
- Red5 Taps PubNub to Power the Next Era of Real-Time Interactive Streaming
- Shoutout Joseph Neibich aka Nybyk
- Meet Joseph Neibich aka Joseph Nybyk of Beachwood Canyon
- LARUS Launches Business Continuity Framework for IPv4-Dependent Networks
- KeysCaribbean Offers 'Skip-the-Crowds' Savings With 15 Percent Off April Stays
- Supply & Demand Chain Executive Names Puga Sankara as Recipient of 2026 Pros to Know Award
- AI Disruption Meets Marine Scale: Off The Hook YS, Inc. (N Y S E American: OTH) Targets Breakout Growth with NextBoat Launch and Aggressive Expansion
- Targeting the Billion-Dollar U.S. Countermeasure Market With AI-Driven Biodefense Platform: Lunai Bioworks (N A S D A Q: LNAI)
- New Global Standard for Transparency Across Critical Resources and Energy Markets: SMX (Security Matters) PLC (N A S D A Q: SMX)
- Forced Psychiatric Hospitalization Fails Vulnerable People: CCHR Urges Repeal Amid Rising U.S. Policies
- Surging Into High-Performance AI With $AMD Partnership, Patent Expansion, and Strengthened Balance Sheet: Avalon GloboCare Corp. (N A S D A Q: ALBT)
- Kiko Nation Launches Mobile App to Modernize Livestock Management and Digital Animal Registry